Active, Not Recruiting
Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS
NCT04057898
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- University of California Orange, California, United States
- Mayo Clinic Jacksonville, Florida, United States
- Augusta University Augusta, Georgia, United States
- Indiana University IU Health Neuroscience Center Indianapolis, Indiana, United States